Editorial: Cardiovascular remodeling

Front Pharmacol. 2023 Jul 24:14:1252598. doi: 10.3389/fphar.2023.1252598. eCollection 2023.

Authors

Yan Yang¹, Yi Zhang², Gui-Rong Li³, Ming Lei⁴

Affiliations

¹ Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China.
² Department of Physiology, Hebei Medical University, Shijiazhuang, China.
³ Nanjing Amazigh Pharma Ltd., Nanjing, China.
⁴ Department of Pharmacology, University of Oxford, Oxford, United Kingdom.

Abstract

Keywords: cardiovascular diseases (CVDs); cardiovascular remodeling; drug therapy; dysfunction; genetic studies.

Publication types

Editorial